WASHINGTON — In the final hours of a lame-duck Congress, lawmakers on Wednesday confirmed the Trump administration’s nominees for science adviser and “drug czar,” following nearly two years in which those White House posts sat vacant.

The confirmation of Kelvin Droegemeier, a former University of Oklahoma professor, means the White House’s Office of Science and Technology Policy will have a director for the first time since the president’s inauguration in January 2017. Droegemeier, a meteorologist, has received largely positive reviews from the scientific community at large, including from John Holdren, the OSTP director during the Obama administration.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • My frustration continues to grow daily at the attacks on the drug industry. I have told friends & family alike the next time your child is ill–decline that antibiotic. When grandma is diagnosed with Parkinson’s—deal with it. Those migraines that are your weekly burden,you are on your OWN. This 21st century has no idea the blessing we have in the intellect,work ethic and skill of the pharmaceutical industry members.

    • True, many advances in medicine have come along, that does not allow for greed & avarice to become acceptable when certain Big Pharma promote drugs to only increase the bottom line.

Your daily dose of news in health and medicine

Privacy Policy